The Effect of Hypertension, Diabetes, and Hyperlipidemia on Medication Intake and Adherence: Analysis from Korean Health Panel Survey 2014-2017

被引:0
作者
Park, Jongho [1 ]
Kim, Yeaeun [2 ]
机构
[1] Gwangju Univ, Dept Publ Hlth Adm, Gwangju, South Korea
[2] Catholic Univ Pusan, Dept Hlth Care Management, Busan, South Korea
关键词
Chronic disease; Medication adherence; Hypertension; Diabetes mellitus; Hyperlipidemia; POPULATION; MULTIMORBIDITY; NONADHERENCE; PREVENTION; PREVALENCE; ADULTS; TRENDS; RISK;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Hypertension, diabetes, and hyperlipidemia are common chronic diseases in South Korea, and medication is a key factor in managing these diseases and preventing disease advancement to multimorbidity. This study aimed to evaluate the effect of chronic disease on medication intake and adherence among Kore-ans.Methods: This study was conducted utilizing data collected from 5,529 individuals that participated in the Korea Health Panel Survey (KHPS) in 2014-2017. The dependent variables were medication intake and adherence, and independent variables included socioeconomic status and the type of chronic disease. The differences in the medication intake and medication adherence by sociodemographic variables and the type of chronic disease were analyzed by chi-square test. The effect of hypertension, diabetes, and hyperlipidemia on medication intake and adherence was analyzed via multiple logistic regression using SAS statistical software.Results: The rate of medication intake and adherence were significantly different among patients with hyper-tension, diabetes, and hyperlipidemia, especially lower in patients with hyperlipidemia compared to those with hypertension and diabetes. In multiple logistic regression analysis, the probability of medication intake in-creased in female gender, older age, medical aid, medication adherence was higher in married, lower educational level and lower household income. Compared to hyperlipidemia, patients with hypertension and diabetes had more likely to take medication as prescribed.Conclusion: The importance of considering the type of chronic disease in developing and implementing public health programs aiming for improved medication adherence. Targeting better medication intake and adherence for each chronic disease could be a valuable policy strategy to effectively manage chronic diseases as well as prevent their complications.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 45 条
  • [1] Aday L., 2004, EVALUATING HEALTHCAR
  • [2] Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study
    Alkerwi, Ala'a
    Pagny, Sybil
    Lair, Marie-Lise
    Delagardelle, Charles
    Beissel, Jean
    [J]. PLOS ONE, 2013, 8 (03):
  • [3] [Anonymous], 2021, KOREA HLTH PANEL STU
  • [4] Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study
    Balkrishnan, R
    Rajagopalan, R
    Camacho, FT
    Huston, SA
    Murray, FT
    Anderson, RT
    [J]. CLINICAL THERAPEUTICS, 2003, 25 (11) : 2958 - 2971
  • [5] The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
    Bloom, David E.
    Chen, Simiao
    Kuhn, Michael
    McGovern, Mark E.
    Oxley, Les
    Prettner, Klaus
    [J]. JOURNAL OF THE ECONOMICS OF AGEING, 2020, 17
  • [6] Bloom DE, 2012, PROGRAM GLOBAL DEMOG
  • [7] Boo S, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000013713, 10.1097/md.0000000000013713]
  • [8] The importance of cholesterol medication adherence: the need for behavioral change intervention programs
    Bosworth, Hayden B.
    Ngouyombo, Barbara
    Liska, Jan
    Zullig, Leah L.
    Atlani, Caroline
    Beal, Anne C.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 341 - 348
  • [9] CDC, 2020, PEOPL CERT MED COND
  • [10] The 'cost' of medication nonadherence: Consequences we cannot afford to accept
    Chisholm-Burns, Marie A.
    Spivey, Christina A.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2012, 52 (06) : 823 - 826